1,1-dichloroethene increases expression ISO RGD:1624060 6480464 vinylidene chloride results in increased expression of TYROBP mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1624060 6480464 ethylene dichloride results in decreased expression of TYROBP mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1624060 6480464 1, 2-Dimethylhydrazine results in increased expression of TYROBP mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene decreases methylation ISO RGD:1624060 6480464 Dinitrochlorobenzene results in decreased methylation of TYROBP gene CTD PMID:26732893 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TYROBP mRNA CTD PMID:25380136 17alpha-ethynylestradiol multiple interactions ISO RGD:1624060 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYROBP mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1624060 6480464 Ethinyl Estradiol results in increased expression of TYROBP mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1624060 6480464 Estradiol results in increased expression of TYROBP mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1624060 6480464 [decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TYROBP mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TYROBP mRNA CTD PMID:15251184 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TYROBP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1624060 6480464 Tetrachlorodibenzodioxin affects the expression of TYROBP mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TYROBP mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1624060 6480464 Tetrachlorodibenzodioxin results in increased expression of TYROBP mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1624060 6480464 Tetrachlorodibenzodioxin results in decreased expression of TYROBP mRNA CTD PMID:15251184 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:1624060 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1624060 6480464 Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA CTD PMID:17982090 , PMID:18200517 2-butoxyethanol increases expression ISO RGD:1624060 6480464 n-butoxyethanol results in increased expression of TYROBP mRNA CTD PMID:19812364 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of TYROBP mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of TYROBP mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1624060 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of TYROBP mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1624060 6480464 [Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of TYROBP mRNA CTD PMID:15251184 5-aza-2'-deoxycytidine decreases expression ISO RGD:1624060 6480464 Decitabine results in decreased expression of TYROBP mRNA CTD PMID:15251184 7,12-dimethyltetraphene decreases expression ISO RGD:1624060 6480464 9 more ... CTD PMID:32553695 acetamide increases expression EXP 6480464 acetamide results in increased expression of TYROBP mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of TYROBP mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:1351113 6480464 Aflatoxin B1 results in increased methylation of TYROBP gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1351113 6480464 Tretinoin results in increased expression of TYROBP mRNA CTD PMID:12875902 more ... amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of TYROBP mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1351113 6480464 Antirheumatic Agents results in decreased expression of TYROBP mRNA CTD PMID:24449571 bathocuproine disulfonic acid multiple interactions ISO RGD:1351113 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] CTD PMID:15477007 benzo[a]pyrene increases expression ISO RGD:1624060 6480464 Benzo(a)pyrene results in increased expression of TYROBP mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1351113 6480464 Benzo(a)pyrene affects the methylation of TYROBP promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1351113 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 Benzo[k]fluoranthene increases expression ISO RGD:1624060 6480464 benzo(k)fluoranthene results in increased expression of TYROBP mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TYROBP mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1624060 6480464 bisphenol F results in increased expression of TYROBP mRNA CTD PMID:30951980 calcitriol increases expression ISO RGD:1351113 6480464 Calcitriol results in increased expression of TYROBP mRNA CTD PMID:12875902 , PMID:16322758 calcitriol decreases expression ISO RGD:1351113 6480464 Calcitriol results in decreased expression of TYROBP mRNA CTD PMID:26485663 carbon nanotube increases expression ISO RGD:1624060 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:1624060 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1351113 6480464 Cisplatin results in increased expression of TYROBP mRNA CTD PMID:27594783 copper atom decreases expression EXP 6480464 Copper results in decreased expression of TYROBP mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of TYROBP mRNA CTD PMID:30556269 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TYROBP mRNA CTD PMID:27523638 curcumin multiple interactions ISO RGD:1624060 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TYROBP mRNA] CTD PMID:18200517 cyclophosphamide increases expression ISO RGD:1624060 6480464 Cyclophosphamide results in increased expression of TYROBP mRNA CTD PMID:21041162 cyclosporin A decreases expression ISO RGD:1351113 6480464 Cyclosporine results in decreased expression of TYROBP mRNA CTD PMID:27989131 dexamethasone increases expression ISO RGD:1624060 6480464 Dexamethasone results in increased expression of TYROBP mRNA CTD PMID:21041162 dibenz[a,h]anthracene multiple interactions ISO RGD:1351113 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene multiple interactions ISO RGD:1351113 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] affects the expression of TYROBP mRNA CTD PMID:17690111 diclofenac increases expression ISO RGD:1624060 6480464 Diclofenac results in increased expression of TYROBP mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:1624060 6480464 Diethylstilbestrol results in increased expression of TYROBP mRNA CTD PMID:21041162 dioxygen decreases expression ISO RGD:1624060 6480464 Oxygen deficiency results in decreased expression of TYROBP mRNA CTD PMID:24205000 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of TYROBP mRNA CTD PMID:33729688 entinostat increases expression ISO RGD:1351113 6480464 entinostat results in increased expression of TYROBP mRNA CTD PMID:27188386 fluoranthene multiple interactions ISO RGD:1351113 6480464 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of TYROBP mRNA CTD PMID:17690111 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of TYROBP mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1624060 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA CTD PMID:20938992 genistein increases expression ISO RGD:1624060 6480464 Genistein results in increased expression of TYROBP mRNA CTD PMID:22553218 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TYROBP mRNA CTD PMID:22061828 ionomycin multiple interactions ISO RGD:1351113 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] more ... CTD PMID:15477007 irinotecan multiple interactions ISO RGD:1624060 6480464 [PHY 906 co-treated with Irinotecan] affects the expression of TYROBP mRNA CTD PMID:32812032 kainic acid increases expression ISO RGD:1624060 6480464 Kainic Acid results in increased expression of TYROBP mRNA CTD PMID:17997037 L-methionine multiple interactions ISO RGD:1624060 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TYROBP mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:1624060 6480464 Lipopolysaccharides results in increased expression of TYROBP mRNA CTD PMID:27339419 methotrexate decreases expression ISO RGD:1351113 6480464 Methotrexate results in decreased expression of TYROBP mRNA CTD PMID:17400583 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TYROBP mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of TYROBP mRNA CTD PMID:25380136 nickel atom increases expression ISO RGD:1351113 6480464 Nickel results in increased expression of TYROBP mRNA CTD PMID:24768652 , PMID:25583101 paracetamol affects expression ISO RGD:1624060 6480464 Acetaminophen affects the expression of TYROBP mRNA CTD PMID:17562736 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1351113 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] more ... CTD PMID:15477007 pirinixic acid decreases expression ISO RGD:1624060 6480464 pirinixic acid results in decreased expression of TYROBP mRNA CTD PMID:17426115 pyrrolidine dithiocarbamate multiple interactions ISO RGD:1351113 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA], pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] CTD PMID:15477007 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of TYROBP mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of TYROBP mRNA CTD PMID:28374803 sodium arsenite affects expression ISO RGD:1351113 6480464 sodium arsenite affects the expression of TYROBP mRNA CTD PMID:29319823 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of TYROBP protein CTD PMID:30273629 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of TYROBP mRNA CTD PMID:25905778 sulforaphane increases expression ISO RGD:1351113 6480464 sulforaphane results in increased expression of TYROBP mRNA CTD PMID:26833863 tamibarotene increases expression ISO RGD:1351113 6480464 tamibarotene results in increased expression of TYROBP mRNA CTD PMID:15498508 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TYROBP mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO RGD:1624060 6480464 Carbon Tetrachloride results in increased expression of TYROBP mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane affects expression ISO RGD:1624060 6480464 Carbon Tetrachloride affects the expression of TYROBP mRNA CTD PMID:31919559 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TYROBP mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TYROBP mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1624060 6480464 titanium dioxide results in increased expression of TYROBP mRNA CTD PMID:23409001 , PMID:23557971 trimellitic acid decreases methylation ISO RGD:1624060 6480464 trimellitic acid results in decreased methylation of TYROBP gene CTD PMID:26732893 trimellitic acid increases methylation ISO RGD:1624060 6480464 trimellitic acid results in increased methylation of TYROBP gene CTD PMID:26732893 troglitazone increases expression ISO RGD:1624060 6480464 troglitazone results in increased expression of TYROBP mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1624060 6480464 Tungsten results in decreased expression of TYROBP mRNA CTD PMID:30912803 valproic acid increases methylation ISO RGD:1351113 6480464 Valproic Acid results in increased methylation of TYROBP gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1351113 6480464 Valproic Acid results in decreased expression of TYROBP mRNA CTD PMID:29154799 vancomycin decreases expression ISO RGD:1624060 6480464 Vancomycin results in decreased expression of TYROBP mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of TYROBP mRNA CTD PMID:19015723 , PMID:23034163
